CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have ...
Phase 2
Toronto, Ontario, Canada and 41 other locations
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic d...
Phase 2
Mississauga, Ontario, Canada and 22 other locations
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Phase 2
Mississauga, Ontario, Canada and 39 other locations
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Phase 2
Toronto, Ontario, Canada and 84 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Phase 3
Mississauga, Ontario, Canada and 88 other locations
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...
Phase 2
Mississauga, Ontario, Canada and 88 other locations
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with mode...
Phase 3
Mississauga, Ontario, Canada and 95 other locations
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Phase 2
Toronto, Ontario, Canada and 60 other locations
The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...
Phase 2
Toronto, Ontario, Canada and 100 other locations
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Phase 2
Markham, Ontario, Canada and 110 other locations
Clinical trials
Research sites
Resources
Legal